Oslo University Hospital: Heart Diseases trials
The registry lists 17 Heart Diseases studies with Oslo University Hospital as lead sponsor. 1 are open to participants now and 1 have results posted.
Early Phase 1 2Phase 2 1No phase 14(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Non-Invasive Method for Evaluation of Cardiac Resynchronization TherapyRecruitingNCT05868616
- Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow upCompletedNCT01412554Results posted
- Theophylline Effects in the Fontan CirculationCompletedNCT05717049Phase 2
- Personalized Mobile App for Parents of Infants With Cardiac DiseaseCompletedNCT04315610Not applicable
- Fetal Growth and Pregnancy Complications Among Women With Heart DiseaseStatus unknownNCT03657823
- Adipose Tissue and Inflammation in Coronary Heart DiseaseActive, not recruitingNCT02760914
- Fontan Circulation and Cardiopulmonary Function: Prognostic Factors, Hemodynamics and Long-term EffectsCompletedNCT02378857
- A Prospective Cohort Study of Heart Patients Included in Exercise Based Rehabilitation in OsloStatus unknownNCT02249260Not applicable
- Severe Aortic Stenosis in Patients Referred for Valve SurgeryStatus unknownNCT01794832
- Active With Heart DiseaseStatus unknownNCT01624818Early Phase 1
- Outcomes in Patients and Their Closest Relatives Treated for Congenital Heart Disease With Catheter Based or Surgical TechniquesStatus unknownNCT01421030Early Phase 1
- Supporting Patient Provider Communication in Paediatric CareCompletedNCT01280227Not applicable
- After Eighty StudyStatus unknownNCT01255540
- Exercise Training in Patients With Coronary Heart Disease and Type 2 DiabetesCompletedNCT01232608Not applicable
- Long Term Vascular Changes in Type 1 DiabetesCompletedNCT00991575
- Reversibility by Sildenafil of Exercise-Induced Abnormal Right Ventricular Pressure Response in ASD and VSD-Operated PatientsStatus unknownNCT00772135Not applicable
- Dairy Products and Metabolic Effects (Norwegian Part)CompletedNCT00140816Not applicable